Aurora Cannabis Announces Fiscal 2021 Second Quarter Results
News provided by
Share this article
Share this article
Total Cannabis Net Revenue of $70.3 Million, Excluding Provisions of $2.7 Million, Up 11% over Q2 2020
Medical Cannabis Net Revenue of $38.9 Million, Up 42% Versus Q2 2020, Driven by a 562% Increase in High Margin International Medical Sales
Adjusted EBITDA Loss, excluding Provisions and Termination Costs, of $12.1 Million Represents an Improvement of $53.1 Million Over Q2 2020; Current Loss Triggered by Several Decisions Expected to Boost Long-Term Profitability
Improved Cash Use by More Than 74% Versus Q2 2020; Cash on Hand at February 10, 2021 of $565 Million
NYSE | TSX: ACB
Company or
Aurora ) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the second quarter of fiscal 2021 ended December 31, 2020.
We re #33!: TSX ekes out gain in pandemic-ravaged 2020
Ian Vandaelle, BNN Bloomberg VIDEO SIGN OUT
2020 will go down in financial market history as one of the most dramatic years on record.
The global pandemic prompted unprecedented lockdowns, a tsunami of fiscal and monetary stimulus, and the most volatile swings on equity markets in a generation. Torontoâs benchmark S&P/TSX Composite Index plunged 37 per cent from peak to trough, then clawed its way back to post a 2.17 per cent gain in 2020. Thatâs good for 33rd out of 92 major global indices, with the TSX sandwiched between Malaysia and Norway in terms of total 2020 returns, but badly lagging the 16 per cent return on the S&P 500 as surging tech stocks turbocharged the bounceback south of the border.
Aurora Cannabis laying off 214 workers, chief science officer to retire thereminder.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thereminder.ca Daily Mail and Mail on Sunday newspapers.